T 0291/22 (GLP-1 compositions/NOVO NORDISK) of 13.09.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T029122.20240913
- Date of decision
- 13 September 2024
- Case number
- T 0291/22
- Petition for review of
- -
- Application number
- 13709231.8
- IPC class
- A61K 38/26A61P 3/10A61K 47/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions of GLP-1 peptides and preparation thereof
- Applicant name
- Novo Nordisk A/S
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Galenicum Health S.L.U.
Hexal AG
Generics (U.K.) Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.